LignaMed Announces Publication of Data on Lead Candidate LGM2605 Demonstrating Protective Effect on Airway Hyperreactivity in Asthma

NEXT STORY
CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook
PREV STORY
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MicroRNA Research Tools, Diagnostics and Therapeutics Markets, 2014-2021

Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: ...

author_avatar
NASDAQ Market News

Ritter Pharmaceuticals, Inc. Prices $23,000,000 Public Offering

Los Angeles, California, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

author_avatar
NASDAQ Market News

First Patient Enrolled in Delcath Amended Registration Trial in Metastatic Ocular Melanoma

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an ...

author_avatar
NASDAQ Market News